Literature DB >> 17003202

Definitive treatment of combat casualties at military medical centers.

Romney C Andersen1, H Michael Frisch, Gerald L Farber, Roman A Hayda.   

Abstract

More than 9,000 casualties have been evacuated during the current conflict, and more than 40,000 orthopaedic surgical procedures have been performed. The most severely injured patients are treated in the United States at military medical centers. Individualized reconstructive plans are developed, and patients are treated with state-of-the-art techniques. Rehabilitation includes the assistance of the physical medicine and rehabilitation, physical therapy, and occupational therapy services, as well as, when necessary, psychiatric or other services. The extreme challenges of treating war-related soft-tissue defects include neurovascular injuries, burns, heterotopic ossification, infection, prolonged recovery, and persistent pain. Such injuries do not allow full restoration of function. Because of such devastating injuries, and despite use of up-to-date methods, outcomes can be less than optimal.

Entities:  

Mesh:

Year:  2006        PMID: 17003202     DOI: 10.5435/00124635-200600001-00006

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  3 in total

1.  Treatment of war wounds: a historical review.

Authors:  M M Manring; Alan Hawk; Jason H Calhoun; Romney C Andersen
Journal:  Clin Orthop Relat Res       Date:  2009-02-14       Impact factor: 4.176

2.  Definitive External Fixation for Anterior Stabilization of Combat-related Pelvic Ring Injuries, With or Without Sacroiliac Fixation.

Authors:  Benjamin W Hoyt; Alexander E Lundy; Richard L Purcell; Colin J Harrington; Wade T Gordon
Journal:  Clin Orthop Relat Res       Date:  2020-04       Impact factor: 4.755

3.  Cross-border firing and injury patterns.

Authors:  Nital Gupta; Shafiq Hackla; Virendar Bhagat; Satvir Singh; Farid Hussain; Anil Gupta
Journal:  J Emerg Trauma Shock       Date:  2016 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.